Discontinuation of total parenteral nutrition in a patient with acquired immunodeficiency syndrome: a Canadian perspective.
Provision of nourishment to terminally ill patients has been a controversial topic in clinical medicine. Determination of the limits of palliative care requires an understanding of the disease process, as well as the boundaries of patient self-determination. With the advent of living wills, the determination of the patient to limit care, including nutrition support, has become socially acceptable. Difficulties arise when there are differences of opinion between the caregiver and the patient. The solutions to these conflicts are often decided in the courtroom, as demonstrated by the Cruzan and Quinlan cases. Living wills are often written to prevent unnecessary financial burdens in hopeless situations. As well, financial considerations influence the decisions made by caregivers in providing care to terminally ill patients. The following case report illustrates the conflict between patient self-determination and limitation of care for financial reasons. The use of substituted judgment within the Canadian health care system and the role of team meetings to resolve ethical decisions are discussed.
Nutrition Support Service, Deaconess Hospital, Evansville, IN.
J B
JB
Knowles
N
N
Gilmore
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000628:therapy*; D000328:Adult; D002170:Canada; D003457:Cryptosporidiosis / Q000188:drug therapy / Q000628:therapy*; D003967:Diarrhea / Q000469:parasitology / Q000628:therapy; D015507:Drugs, Investigational / Q000627:therapeutic use; D004992:Ethics, Medical; D015276:Health Care Rationing; D006801:Humans; D008297:Male; D009570:Nitriles / Q000627:therapeutic use; D010289:Parenteral Nutrition, Total; D016079:Refusal to Treat; D015572:Spiramycin / Q000627:therapeutic use; D017211:Treatment Failure; D014227:Triazines / Q000627:therapeutic use
D015507:Drugs, Investigational; D009570:Nitriles; D014227:Triazines; D015572:Spiramycin; C057884:diclazuril